- Home
- NERV vs VISL Comparison
NERV vs VISL Comparison
Compare NERV & VISL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- VISL
- Stock Information
- Founded
- NERV 2007
- VISL 2002
- Country
- NERV United States
- VISL United States
- Employees
- NERV N/A
- VISL N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- VISL Telecommunications Equipment
- Sector
- NERV Health Care
- VISL Telecommunications
- Exchange
- NERV Nasdaq
- VISL Nasdaq
- Market Cap
- NERV 18.3M
- VISL 14.9M
- IPO Year
- NERV 2014
- VISL N/A
- Fundamental
- Price
- NERV $2.20
- VISL $4.35
- Analyst Decision
- NERV Hold
- VISL
- Analyst Count
- NERV 1
- VISL 0
- Target Price
- NERV $5.00
- VISL N/A
- AVG Volume (30 Days)
- NERV 25.3K
- VISL 22.1K
- Earning Date
- NERV 11-05-2024
- VISL 11-14-2024
- Dividend Yield
- NERV N/A
- VISL N/A
- EPS Growth
- NERV N/A
- VISL N/A
- EPS
- NERV N/A
- VISL N/A
- Revenue
- NERV N/A
- VISL $32,438,000.00
- Revenue This Year
- NERV N/A
- VISL $30.41
- Revenue Next Year
- NERV N/A
- VISL $11.96
- P/E Ratio
- NERV N/A
- VISL N/A
- Revenue Growth
- NERV N/A
- VISL 19.86
- 52 Week Low
- NERV $2.10
- VISL $2.77
- 52 Week High
- NERV $13.49
- VISL $8.15
- Technical
- Relative Strength Index (RSI)
- NERV 34.31
- VISL 26.02
- Support Level
- NERV $2.26
- VISL $3.70
- Resistance Level
- NERV $2.43
- VISL $6.74
- Average True Range (ATR)
- NERV 0.16
- VISL 0.45
- MACD
- NERV -0.01
- VISL -0.16
- Stochastic Oscillator
- NERV 13.71
- VISL 21.38
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About VISL Vislink Technologies Inc.
Vislink Technologies Inc is a technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the scene of the action to the viewing screen. It provides solutions for the collection of live news, sports, and entertainment events for the broadcast markets. It also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The company provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.